Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Dow
Harvard Business School
Boehringer Ingelheim
Mallinckrodt

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Isoquinoline

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Isoquinoline: Patents, clinical trial progress, indications

Isoquinoline is an investigational drug.

There have been 10 clinical trials for Isoquinoline. The most recent clinical trial was a Phase 1 trial, which was initiated on July 1st 2018.

The most common disease conditions in clinical trials are Taeniasis, Neurocysticercosis, and Cysticercosis. The leading clinical trial sponsors are National Institute of Mental Health (NIMH), University of Washington, and Kenya Medical Research Institute.

There are eight hundred and ninety-one US patents protecting this investigational drug and eleven international patents.

Recent Clinical Trials for Isoquinoline
TitleSponsorPhase
Comparation of Berberine and Metformin for the Treatment for MS in Schizophrenia PatientsTianjin Anding HospitalPhase 4
Assessing Goldenseal-drug Interactions Using a Probe Drug Cocktail ApproachNational Center for Complementary and Integrative Health (NCCIH)Early Phase 1
Assessing Goldenseal-drug Interactions Using a Probe Drug Cocktail ApproachWashington State UniversityEarly Phase 1

See all Isoquinoline clinical trials

Clinical Trial Summary for Isoquinoline

Top disease conditions for Isoquinoline
Top clinical trial sponsors for Isoquinoline

See all Isoquinoline clinical trials

US Patents for Isoquinoline

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Isoquinoline   Start Trial Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses Bristol-Myers Squibb Company (Princeton, NJ)   Start Trial
Isoquinoline   Start Trial Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors Incyte Corporation (Wilmington, DE)   Start Trial
Isoquinoline   Start Trial Crystalline dimethyl 3-(benzyloxy)-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2,5-dicarb- oxylate Shionogi & Co., Ltd (JP)   Start Trial
Isoquinoline   Start Trial Organic electroluminescent materials and devices Universal Display Corporation (Ewing, NJ)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Isoquinoline

Drugname Country Document Number Estimated Expiration Related US Patent
Isoquinoline Argentina 094452 2032-11-08   Start Trial
Isoquinoline Australia 2013341186 2032-11-08   Start Trial
Isoquinoline Australia 2017201076 2032-11-08   Start Trial
Isoquinoline Australia 2018267545 2032-11-08   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Dow
Harvard Business School
Medtronic
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.